Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Liothyronine Market by Type (Purity 97%, Purity 98%, Purity 99%, Other), By Application (Chemical Reagents, Pharmaceutical Intermediates, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Liothyronine Market by Type (Purity 97%, Purity 98%, Purity 99%, Other), By Application (Chemical Reagents, Pharmaceutical Intermediates, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 138970 3300 Pharma & Healthcare 377 239 Pages 5 (49)
                                          

Market Overview:


The global liothyronine market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of thyroid disorders, increasing demand for liothyronine in chemical reagents and pharmaceutical intermediates applications, and growing investments by key players in R&D activities. However, stringent regulatory norms for drug approvals are likely to restrain the growth of the market during the forecast period. Based on type, the global liothyronine market is segmented into purity 97%, purity 98%, purity 99%, and other segments. The purity 97% segment is expected to account for a major share of the global liothyronine market during the forecast period owing to its high demand from end-use industries such as chemical reagents and pharmaceutical intermediates.


Global Liothyronine Industry Outlook


Product Definition:


Liothyronine is a synthetic thyroid hormone used to treat hypothyroidism. It is also occasionally used for weight loss and in the treatment of other conditions.


Purity 97%:


Purity 97% is a form of L-tryptophan that has been processed to remove all other amino acids from the molecule. It's appearance as a white powder and its odorless properties make it ideal for use in pharmaceuticals and dietary supplements. Increasing demand for products with natural ingredients is expected to be one of the key drivers for this market over the forecast period.


Purity 98%:


Purity 98% is a raw material used in the production of Liothyronine. It is also known as Levoxyl, Tirosint or N-Tirosin. Purity 98% has been tested and found to be free from all kinds of impurities and contains no other chemical substances than that specified on the label.


Application Insights:


The other application segment includes the use of liothyronine for research purposes and in the treatment of disease. The chemical is used as a chemical reagent in various laboratories across the world. It is also used as an intermediate in drug discovery and development processes by several companies and institutions. However, major applications are found outside these sectors such as pharmaceutical intermediates, where it is utilized to produce thyroid hormones under Good Manufacturing Practice (GMP) conditions.


Liothyronine has been approved by U.S.


Regional Analysis:


Asia Pacific dominated the global Liothyronine market in 2017. The presence of key manufacturers and suppliers coupled with a robust manufacturing base for pharmaceuticals, chemicals, and other industries is expected to drive the regional demand over the forecast period.


China accounted for approximately 45% of Asia Pacific market volume in 2017 owing to its robust production capacity and availability of low-cost raw materials such as triacalcitol as well as labor. Furthermore, increasing healthcare expenditure coupled with growing awareness regarding thyroid disorders is anticipated to fuel growth over the forecast period.


Growth Factors:


  • Increasing prevalence of thyroid disorders: The global prevalence of thyroid disorders is increasing at a rapid pace. This is primarily attributed to the changing lifestyle and dietary habits. According to a study by the World Health Organization, the number of people suffering from thyroid disorders is expected to reach more than 717 million by 2020. This will create significant growth opportunities for the Liothyronine market in the coming years.
  • Growing awareness about thyroid diseases: There is a growing awareness among people about different types of thyroid diseases and their symptoms. This has led to an increase in the number of patients seeking medical help for diagnosis and treatment of these diseases. This will boost demand for Liothyronine in the coming years.

Scope Of The Report

Report Attributes

Report Details

Report Title

Liothyronine Market Research Report

By Type

Purity 97%, Purity 98%, Purity 99%, Other

By Application

Chemical Reagents, Pharmaceutical Intermediates, Other

By Companies

TCI, HBCChem, Toronto Research Chemicals, Waterstone Technology, Alfa Aesar, 3B Scientific, VWR International, Suzhou Ryan Pharmaceutical Technology, J & K SCIENTIFIC, Meryer Chemical Technology

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

239

Number of Tables & Figures

168

Customization Available

Yes, the report can be customized as per your need.


Global Liothyronine Market Report Segments:

The global Liothyronine market is segmented on the basis of:

Types

Purity 97%, Purity 98%, Purity 99%, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Chemical Reagents, Pharmaceutical Intermediates, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. TCI
  2. HBCChem
  3. Toronto Research Chemicals
  4. Waterstone Technology
  5. Alfa Aesar
  6. 3B Scientific
  7. VWR International
  8. Suzhou Ryan Pharmaceutical Technology
  9. J & K SCIENTIFIC
  10. Meryer Chemical Technology

Global Liothyronine Market Overview


Highlights of The Liothyronine Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Purity 97%
    2. Purity 98%
    3. Purity 99%
    4. Other
  1. By Application:

    1. Chemical Reagents
    2. Pharmaceutical Intermediates
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Liothyronine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Liothyronine Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Liothyronine is a medication used to treat thyroid problems. It works by increasing the amount of thyroid hormone in the body.

Some of the major players in the liothyronine market are TCI, HBCChem, Toronto Research Chemicals, Waterstone Technology, Alfa Aesar, 3B Scientific, VWR International, Suzhou Ryan Pharmaceutical Technology, J & K SCIENTIFIC, Meryer Chemical Technology.

The liothyronine market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Liothyronine Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Liothyronine Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Liothyronine Market - Supply Chain
   4.5. Global Liothyronine Market Forecast
      4.5.1. Liothyronine Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Liothyronine Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Liothyronine Market Absolute $ Opportunity

5. Global Liothyronine Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Liothyronine Market Size and Volume Forecast by Type
      5.3.1. Purity 97%
      5.3.2. Purity 98%
      5.3.3. Purity 99%
      5.3.4. Other
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Liothyronine Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Liothyronine Market Size and Volume Forecast by Application
      6.3.1. Chemical Reagents
      6.3.2. Pharmaceutical Intermediates
      6.3.3. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Liothyronine Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Liothyronine Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Liothyronine Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Liothyronine Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Liothyronine Demand Share Forecast, 2019-2029

9. North America Liothyronine Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Liothyronine Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Liothyronine Market Size and Volume Forecast by Application
      9.4.1. Chemical Reagents
      9.4.2. Pharmaceutical Intermediates
      9.4.3. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Liothyronine Market Size and Volume Forecast by Type
      9.7.1. Purity 97%
      9.7.2. Purity 98%
      9.7.3. Purity 99%
      9.7.4. Other
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Liothyronine Demand Share Forecast, 2019-2029

10. Latin America Liothyronine Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Liothyronine Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Liothyronine Market Size and Volume Forecast by Application
      10.4.1. Chemical Reagents
      10.4.2. Pharmaceutical Intermediates
      10.4.3. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Liothyronine Market Size and Volume Forecast by Type
      10.7.1. Purity 97%
      10.7.2. Purity 98%
      10.7.3. Purity 99%
      10.7.4. Other
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Liothyronine Demand Share Forecast, 2019-2029

11. Europe Liothyronine Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Liothyronine Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Liothyronine Market Size and Volume Forecast by Application
      11.4.1. Chemical Reagents
      11.4.2. Pharmaceutical Intermediates
      11.4.3. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Liothyronine Market Size and Volume Forecast by Type
      11.7.1. Purity 97%
      11.7.2. Purity 98%
      11.7.3. Purity 99%
      11.7.4. Other
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Liothyronine Demand Share, 2019-2029

12. Asia Pacific Liothyronine Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Liothyronine Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Liothyronine Market Size and Volume Forecast by Application
      12.4.1. Chemical Reagents
      12.4.2. Pharmaceutical Intermediates
      12.4.3. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Liothyronine Market Size and Volume Forecast by Type
      12.7.1. Purity 97%
      12.7.2. Purity 98%
      12.7.3. Purity 99%
      12.7.4. Other
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Liothyronine Demand Share, 2019-2029

13. Middle East & Africa Liothyronine Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Liothyronine Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Liothyronine Market Size and Volume Forecast by Application
      13.4.1. Chemical Reagents
      13.4.2. Pharmaceutical Intermediates
      13.4.3. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Liothyronine Market Size and Volume Forecast by Type
      13.7.1. Purity 97%
      13.7.2. Purity 98%
      13.7.3. Purity 99%
      13.7.4. Other
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Liothyronine Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Liothyronine Market: Market Share Analysis
   14.2. Liothyronine Distributors and Customers
   14.3. Liothyronine Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. TCI
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. HBCChem
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Toronto Research Chemicals
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Waterstone Technology
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Alfa Aesar
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. 3B Scientific
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. VWR International
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Suzhou Ryan Pharmaceutical Technology
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. J & K SCIENTIFIC
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Meryer Chemical Technology
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us